Experimental Alzheimer’s drug gets FDA advisory panel’s thumbs-up: ‘Progress is happening’

An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel on Monday. Industry experts and doctors shared reactions.An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration advisory panel on Monday. Industry experts and doctors shared reactions.Read Moreaa6e6021-05fe-5763-b193-dbfa00e87862, fox-news/health, fox-news/health/nervous-system-health/alzheimers, fox-news/health/healthy-living/medications, fox-news/health/medical-research, fox-news/lifestyle, fox-news/health/geriatric-health, fnc, fox-news/health, article, Fox News, Melissa RudyFOX News : Health